Skip to main content
Clinical Trials/NCT05412511
NCT05412511
Completed
Not Applicable

Metabolic Cost of Medicine Ball Training

University of Thessaly1 site in 1 country10 target enrollmentMay 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Body Composition
Sponsor
University of Thessaly
Enrollment
10
Locations
1
Primary Endpoint
Change in exercise-induced energy expenditure
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In this study, the investigators will be able to estimate the metabolic cost of several foundational medicine ball training exercises.

Detailed Description

Medicine ball training has become a popular cardiovascular training choice in fitness centers and athletic performance enhancement facilities. Despite widespread use and growing popularity, little is known about the metabolic demands of such a training method. Therefore, the purpose of this study was to quantify the cardiovascular and metabolic cost from various foundational medicine ball exercises in order to contribute to a better planning of exercise programs in the real world. Ten healthy young adults were assigned to execute fourteen bodyweight exercises (acute bout) of which seven exercises will be executed by throwing the medicine ball and seven exercises will be executed without a medicine ball throw. Anthropometric, metabolic, functional capacity and performance measurements were conducted at baseline. The metabolic cost was estimated from heart rate, blood lactate, resting oxygen uptake, exercise oxygen uptake, and excess post-exercise oxygen consumption measurements using a portable gas analyzer.

Registry
clinicaltrials.gov
Start Date
May 1, 2022
End Date
April 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ioannis G. Fatouros

Professor

University of Thessaly

Eligibility Criteria

Inclusion Criteria

  • Aged between 18 and 35 years
  • Physically active individuals
  • Free of chronic diseases
  • Free of musculoskeletal injuries
  • Nonsmokers

Exclusion Criteria

  • Musculoskeletal injuries
  • Chronic diseases
  • Use of alcohol, caffeine and any type of ergogenic supplements or medication before (≤6 months) and throughout the study.

Outcomes

Primary Outcomes

Change in exercise-induced energy expenditure

Time Frame: At pre-exercise, during, and 30 minutes after the exercise session (a single bout lasting 30 seconds)

Exercise energy expenditure (kcal) will be measured using a portable indirect calorimetry system

Change in excess post-exercise oxygen consumption (EPOC)

Time Frame: At 1 hour after exercise session (single bout lasting 30 seconds)

EPOC (kcal) will be measured using a portable indirect calorimetry system

Change in blood lactate concentration (BLa)

Time Frame: At pre-exercise and 3 minutes after exercise session (a single bout lasting 30 seconds)

BLa (mmol/L) concentration will be measured in a microphotometer with commercially available kits.

Change in heart rate

Time Frame: At pre-exercise, during, and 30 minutes after ther exercise session (a single bout lasting 30 seconds)

Heart rate (bpm) will be measured with a wearable heart rate monitor

Change in perceived exertion

Time Frame: At pre-exercise, during, and 30 minutes after the exercise session (a single bout lasting 30 seconds)

Rating of perceived exertion (RPE) will be measured with the Borg scale (0-10)

Secondary Outcomes

  • Body weight(At baseline)
  • Body height(At baseline)
  • Body mass index (BMI)(At baseline)
  • Waist circumference (WC)(At baseline)
  • Hip circumference (HC)(At baseline)
  • Waist-to-hip ratio (WHR(At baseline)
  • Resting metabolic rate (RMR)(At baseline)
  • Body fat (BF) Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)(At baseline)
  • Fat mass (FM)t Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)(At baseline)
  • Fat-free mass (FFM)(At baseline)
  • Maximal oxygen consumption (VO2max)(At baseline)
  • Maximal strength (1RM)(At baseline)
  • Muscular endurance(At baseline)
  • Functional capacity(At baseline)

Study Sites (1)

Loading locations...

Similar Trials